Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trulicity for Stress Hyperglycemia in Cardiac Surgery
NCT03743025Phase 4Terminated
- Sponsor
- Emory University
- Start
- Mar 2019
- Primary completion
- May 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of dulaglutide in Stress Hyperglycemia (SH), sponsored by Emory University. Started Mar 2019; status: terminated.
02
Drugs
dulaglutide
03
Conditions
Stress Hyperglycemia (SH)
Beyond the preview
Go deeper on NCT03743025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03743025.